Explore how peptide drugs are changing the hundred-billion-level weight loss market, and how this landscape is changing as ...
UC Davis researchers have developed a new method that uses light to transform amino acids—the building blocks of ...
News-Medical.Net on MSN
Low-dose megestrol strengthens hormone therapy in ER-positive breast cancer
Low-dose megestrol enhances hormone therapy for ER-positive breast cancer, reducing tumor proliferation and improving ...
Company believes that data from sunRIZE and the Expanded Access Program (EAP) provide evidence of activity of ersodetug in ...
Triple-negative breast cancer (TNBC) is among the most aggressive types of breast cancer, lacking estrogen, progesterone, and ...
Delivers rapid, durable responses in wAIHA, the more common form of this potentially life-threatening disease — HONG KONG and SHANGHAI and ...
UC Davis researchers have developed a new method that uses light to transform amino acids — the building blocks of proteins — into molecules that are ...
As of Wednesday, January 07, CytomX Therapeutics, Inc.’s CTMX share price has surged by 6.40%, which has investors questioning if this is right time to sell.
Rakuten Medical has added to its tally of mega-rounds, pocketing another $100 million to push its lead light-based cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback